Detalhe da pesquisa
1.
The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus.
Cell Mol Life Sci;
80(11): 326, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37833515
2.
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Gut;
72(6): 1186-1195, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35977815
3.
Hepatitis E virus prevalence in Flemish blood donors.
J Viral Hepat;
26(10): 1218-1223, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31194897
4.
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.
Hepatology;
63(4): 1120-34, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26710081
5.
Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays.
Viruses;
15(12)2023 12 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38140653
6.
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection.
JHEP Rep;
5(3): 100646, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36748051
7.
A Role for B Cells to Transmit Hepatitis C Virus Infection.
Front Immunol;
12: 775098, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34975862
8.
Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies.
J Gen Virol;
91(Pt 3): 643-52, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19889923
9.
Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice.
Hepatology;
49(1): 39-49, 2009 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19085971
10.
Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
Virology;
514: 30-41, 2018 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29128754
11.
A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.
Antiviral Res;
148: 53-64, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29074219
12.
Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
Clin Chim Acta;
366(1-2): 156-62, 2006 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16253217
13.
The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate.
J Gen Virol;
86(Pt 1): 75-84, 2005 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15604433
14.
Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked.
J Gen Virol;
86(Pt 2): 323-331, 2005 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15659751
15.
Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor.
J Gen Virol;
83(Pt 6): 1281-1289, 2002 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12029142
16.
Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity.
J Med Virol;
70(4): 513-9, 2003 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12794712
17.
Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes.
Biochem Biophys Res Commun;
297(3): 486-91, 2002 Sep 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12270119
18.
LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles.
J Gen Virol;
83(Pt 9): 2279-2289, 2002 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12185283
19.
Contamination of a recombinant hepatitis B virus nucleocapsid preparation with a human B-cell activator.
J Virol;
81(5): 2535-6, 2007 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17151106